The Vascade MVP venous vascular closure system got FDA approval for multi-site venous closure in electrophysiology procedures, Cardiva Medical announced. The collagen patch device stops bleeding then absorbs into the body.
Transcatheter aortic valve replacement (TAVR) improved survival for cancer patients with severe aortic stenosis compared to medical therapy alone, a small study showed in Catheterization and Cardiovascular Interventions.
Delirium after aortic valve replacement was associated with patients spending an extra 4.16 days and $15,592 more at the hospital, according to Medicare data. Delirium was less common after TAVR than surgery. (Catheterization and Cardiovascular Interventions)
CoreValve bioprosthetic valves placed at one Italian center were said to have “excellent durability” over 7-year follow-up: rates of structural valve deterioration and bioprosthetic valve failure were 3.6% and 2.5%, respectively. (EuroIntervention)
The transradial approach was tied to a lower periprocedural stroke risk in percutaneous coronary intervention (PCI) in a Japanese registry. (Circulation: Cardiovascular Interventions)
Revascularization outcomes were similar whether patients with left main coronary artery disease and prior cerebrovascular disease underwent PCI or coronary artery bypass grafting, according to an EXCEL substudy in JACC: Cardiovascular Interventions.
The Vetex thrombectomy catheter removed wall-adherent deep vein thrombosis without thrombolytic drugs in the first case from a 30-person feasibility study, Vetex Medical announced.
Source: MedicalNewsToday.com
